Susquehanna International Group, LLP Nuvation Bio Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 14,485 shares of NUVB stock, worth $37,516. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,485

Previous 20,299 28.64%

Holding current value

$37,516

Previous $59,000 44.07%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.3 - $3.83 $13,372 - $22,267	-5,814 Reduced 28.64%	14,485 $33,000
Q2 2024 Aug 15, 2024	BUY	$2.58 - $3.69 $52,371 - $74,903	20,299 New	20,299 $59,000
Q4 2023 Feb 14, 2024	BUY	$0.96 - $1.53 $134,266 - $213,987	139,861 Added 983.41%	154,083 $232,000
Q3 2023 Nov 14, 2023	SELL	$1.26 - $2.1 $40,170 - $66,950	-31,881 Reduced 69.15%	14,222 $19,000
Q2 2023 Aug 11, 2023	SELL	$1.56 - $1.84 $113,031 - $133,319	-72,456 Reduced 61.11%	46,103 $82,000
Q1 2023 May 16, 2023	BUY	$1.6 - $2.48 $149,097 - $231,101	93,186 Added 367.26%	118,559 $196,000
Q4 2022 Feb 14, 2023	SELL	$1.68 - $2.5 $84,500 - $125,745	-50,298 Reduced 66.47%	25,373 $48,000
Q3 2022 Nov 14, 2022	BUY	$0.29 - $4.04 $21,944 - $305,710	75,671 New	75,671 $170,000
Q2 2022 Aug 15, 2022	SELL	$3.24 - $5.85 $38,319 - $69,187	-11,827 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.6 - $8.83 $222,446 - $427,001	-48,358 Reduced 80.35%	11,827 $62,000
Q4 2021 Feb 14, 2022	BUY	$7.75 - $10.05 $291,136 - $377,538	37,566 Added 166.08%	60,185 $512,000
Q3 2021 Nov 15, 2021	SELL	$7.78 - $10.0 $387,490 - $498,060	-49,806 Reduced 68.77%	22,619 $225,000
Q2 2021 Aug 11, 2021	BUY	$9.22 - $14.48 $362,226 - $568,875	39,287 Added 118.56%	72,425 $674,000
Q1 2021 May 17, 2021	BUY	$9.0 - $14.57 $298,242 - $482,820	33,138 New	33,138 $346,000

Others Institutions Holding NUVB

# of Institutions

158

Shares Held

157M

Call Options Held

3.2K

Put Options Held

98.7K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $563M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Nuvation Bio Inc. Transaction History